BGB-3111-216

No longer available

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

Beigene Study ID info

BGB-3111-216

ClinicalTrials.gov ID info

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents